Trust Company of Kansas’s Bristol-Myers Squibb BMY Stock Holding History

Trust Company of Kansas’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,825	Closed	-$279K	–	50
2022 Q1	$279K	Sell	3,825 -53	-1%	-$3.56K	0.15%	45
2021 Q4	$242K	Sell	3,878 -325	-8%	-$19.1K	0.13%	60
2021 Q3	$249K	Hold	4,203	–	–	0.14%	49
2021 Q2	$281K	Buy	4,203 +325	+8%	+$21.2K	0.16%	43
2021 Q1	$245K	Buy	+3,878	New	+$241K	0.16%	41
2020 Q2	–	Sell	-3,943	Closed	-$220K	–	47
2020 Q1	$220K	Sell	3,943 -580	-13%	-$35.5K	0.13%	53
2019 Q4	$290K	Buy	+4,523	New	+$259K	0.17%	36

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Trust Company of Kansas's BMY Position: Q2 2022 in Review

Trust Company of Kansas sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 3,825 shares — an estimated $279K sold.

Trust Company of Kansas first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $290K in Q4 2019. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Trust Company of Kansas reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Trust Company of Kansas sold 3,825 Bristol-Myers Squibb shares in Q2 2022, an estimated $279K.
Trust Company of Kansas first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
Trust Company of Kansas's Bristol-Myers Squibb position peaked at $290K in Q4 2019.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Trust Company of Kansas's 13F filing for Q2 2022, filed 15 Aug 2022.